These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31918276)

  • 1. The role of IL-37 in skin and connective tissue diseases.
    Pan Y; Wen X; Hao D; Wang Y; Wang L; He G; Jiang X
    Biomed Pharmacother; 2020 Feb; 122():109705. PubMed ID: 31918276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Understanding of IL-37 in Human Health and Disease.
    Su Z; Tao X
    Front Immunol; 2021; 12():696605. PubMed ID: 34248996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of inflammation and acquired immunity by IL-37.
    Cavalli G; Dinarello CA
    Immunol Rev; 2018 Jan; 281(1):179-190. PubMed ID: 29247987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
    Nold-Petry CA; Lo CY; Rudloff I; Elgass KD; Li S; Gantier MP; Lotz-Havla AS; Gersting SW; Cho SX; Lao JC; Ellisdon AM; Rotter B; Azam T; Mangan NE; Rossello FJ; Whisstock JC; Bufler P; Garlanda C; Mantovani A; Dinarello CA; Nold MF
    Nat Immunol; 2015 Apr; 16(4):354-65. PubMed ID: 25729923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of IL-37 in Atopic Dermatitis.
    Mesjasz A; Trzeciak M; Gleń J; Jaskulak M
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
    Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
    J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18 and Cutaneous Inflammatory Diseases.
    Lee JH; Cho DH; Park HJ
    Int J Mol Sci; 2015 Dec; 16(12):29357-69. PubMed ID: 26690141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the role of IRF7 in skin and connective tissue diseases.
    Wang L; Yang F; Ye J; Zhang L; Jiang X
    Exp Dermatol; 2024 May; 33(5):e15083. PubMed ID: 38794808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Interleukin-37 in Inflammatory and Autoimmune Diseases.
    Wang X; Xu K; Chen S; Li Y; Li M
    Iran J Immunol; 2018 Sep; 15(3):165-174. PubMed ID: 30246692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18: Biological properties and role in disease pathogenesis.
    Kaplanski G
    Immunol Rev; 2018 Jan; 281(1):138-153. PubMed ID: 29247988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process.
    Gu M; Jin Y; Gao X; Xia W; Xu T; Pan S
    Front Immunol; 2023; 14():1278521. PubMed ID: 37928545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protective role of IL-37 in cancer: a new hope for cancer patients.
    Abulkhir A; Samarani S; Amre D; Duval M; Haddad E; Sinnett D; Leclerc JM; Diorio C; Ahmad A
    J Leukoc Biol; 2017 Feb; 101(2):395-406. PubMed ID: 27881603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases.
    Bai J; Li Y; Li M; Tan S; Wu D
    Curr Drug Targets; 2020; 21(9):855-863. PubMed ID: 32348214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new target for the treatment of inflammatory bowel disease: Interleukin-37.
    Jia Y; Anwaar S; Li L; Yin Z; Ye Z; Huang Z
    Int Immunopharmacol; 2020 Jun; 83():106391. PubMed ID: 32208166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-regulated neutrophilic inflammation in autoinflammatory diseases.
    Keller M; Spanou Z; Schaerli P; Britschgi M; Yawalkar N; Seitz M; Villiger PM; Pichler WJ
    J Immunol; 2005 Dec; 175(11):7678-86. PubMed ID: 16301678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18.
    Dinarello CA
    Methods; 1999 Sep; 19(1):121-32. PubMed ID: 10525448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
    Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
    Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice.
    Lunding L; Webering S; Vock C; Schröder A; Raedler D; Schaub B; Fehrenbach H; Wegmann M
    Allergy; 2015 Apr; 70(4):366-73. PubMed ID: 25557042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.